Valirx Share Price (VAL)
| Bid price | 19.50 | Open price | 19.98 |
|---|---|---|---|
| Ask price | 20.00 | Prev close | 19.75 |
| High price | 0.00 | Spread | 2.50% |
| Low price | 0.00 | Volume | 0 |
Register now for FREE live Valirx share prices, Valirx stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Valirx Level 2 Data, indepth research tools and investor commentary for Valirx (VAL) and other London Stock Exchange equities.
Valirx Share Price Chart
Register now for FREE Valirx share price charts
Valirx Share Price Information
| Name | ValiRx | Epic | VAL |
|---|---|---|---|
| Sector | n/a | ISIN | GB00BLH13C52 |
| Activites | n/a | Index | n/a |
Valirx Director Deals
| Dec.Date | Type | Director | Pos | No. of Shares |
|---|---|---|---|---|
| 31/12/2024 | TIN | Mark Eccleston | CEO | 3,076,923 |
| 30/12/2024 | TIN | Gerald Desler | ED | 769,231 |
| 30/12/2024 | TIN | Adrian de Courcey | RES | 1,538,461 |
| 30/12/2024 | TIN | Catherine Tralau-Stewart | ED | 769,231 |
| 04/01/2024 | PLAC | Gerald Desler | ED | 66,666 |
Valirx Company News
Holding(s) in Company
RNS Number : 9273G ValiRx PLC 30 November 2020 TR-1: S tandard form for notification of major holdings NOTIFICATION OF...
VAL201 Clinical Trial Full Data Results
RNS Number : 8402G ValiRx PLC 30 November 2020 30 November 2020 ("ValiRx", the "Company" or the "Group") VAL201 Clinical Trial Full Data Results Full dataset...
Agreement with Kalos Therapeutics
RNS Number : 7524E ValiRx PLC 10 November 2020 ("ValiRx", the "Company" or the "Group") Agreement with Kalos Therapeutics First project under new strategy to develop pipeline of early stage projects 10 November...
Register now for FREE Valirx company news
Valirx Share Price Discussions
ValiRx Plc - Bioscience Innovation (VAL)
Valirx wants to make a structural change in science, namely to engineer a scientific breakthrough into human health and wellbeing, through early detection of disease and therapeutic intervention. Research shows that there is a high demand for new personalised medicines and services that...
(VAL)
Dr Satu Vainikka, CEO commented: "I am delighted that we are now launching our Chlamydia self-testing product into the UK and Irish markets. With Chlamydia being diagnosed as the fastest growing sexually transmitted disease at the moment, our self-testing pack, as an affordable, easy -to-use...
Register now for FREE Valirx share price discussions